由HPV E6调节的TIGAR与宫癌的疾病阶段,药物敏感性和免疫微环境相关
Yameng Liu1,2, Yu Zhang1,3, Hailong Zhang1,3
1Center for Clinical Laboratories, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
Scientific reports
|July 2, 2025
概括
在宫癌中,TP53诱导的糖解调节酶 (TIGAR) 被上调调节,作为潜在的诊断和预后生物标志物. 提升的TIGAR表达与预后不佳和特定的免疫细胞透相关,这表明它在宫癌免疫治疗中的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 宫癌缺乏特定的诊断和预后标志物.
- TP53诱导的糖解调节酶 (TIGAR) 与各种固体瘤有关.
- 了解TIGAR在宫癌中的作用对于开发新的治疗策略至关重要.
研究的目的:
- 调查TIGAR在宫癌中的诊断和预后价值.
- 探索TIGAR在宫癌中的免疫治疗潜力.
- 分析TIGAR表达与宫癌免疫细胞透之间的相关性.
主要方法:
- 生物信息学分析和实验验证,以评估TIGAR表达.
- 卡普兰-梅尔生存分析以评估预后意义.
- 接收器操作特征 (ROC) 曲线分析用于诊断准确性.
- 与免疫透标记物 (例如,Foxp3+ Treg细胞,CD11b+ MDSC) 和临床队列的相关性分析.
主要成果:
- 在宫癌组织和细胞中,TIGAR的表达显著上调.
- 较高的TIGAR表达与较差的患者预后有关.
- TIGAR在区分宫癌方面显示出诊断价值.
- TIGAR的表达与调节性T细胞 (Treg),骨髓衍生抑制细胞 (MDSC),CTLA4和HAVCR2的透水平相关.
结论:
- TIGAR作为宫癌的潜在诊断和预后生物标志物.
- TIGAR与免疫透的关联表明它在瘤微环境中的作用.
- TIGAR可能为宫癌免疫疗法提供新的治疗点.
更多相关视频
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
9.8K
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
10.6K
相关概念视频
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
